SavedAdd your journal

Journals / European Archives of Medical Research / 2019 / Cilt: 35 - Sayı: 2

Results of the Bethesda System in Patients Undergoing Thyroidectomy-A Single-Center Experience

Sönmez OCAK
Ömer Faruk BÜK
Kürşat YEMEZ
Pages
71–76
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Therefore,multidisciplinary approach should be considered during treatment planning and surgical treatment option should be kept in mind.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: To compare preoperative fine needle aspiration biopsy (FNAB) and postoperative histopathological findings in patients undergoingthyroidectomy and to validate the Bethesda System for Reporting Thyroid Cytopathology (TBSRTC).Methods: Data from 366 patients who underwent thyroidectomy between 2014-2016 were analyzed retrospectively and the variables related tothyroid cancer were investigated.Results: Of 366 patients, 44 (12%) were male and 322 (88%) were female.
📊
Key Findings & Data:Regarding FNAB results according to TBSRTC, 23 (6.3%) patients had categoryI, 79 (21.6%) had category II, 128 (35%) had category III, 113 (30.9%) had category IV, nine (3.8%) patients had category V and 14 (2.5%) had category VIcytology.
💡
Conclusion & Impact:Therefore,multidisciplinary approach should be considered during treatment planning and surgical treatment option should be kept in mind.
🔬Design:Research Article
📍Scope:2014-2016 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: To compare preoperative fine needle aspiration biopsy (FNAB) and postoperative histopathological findings in patients undergoingthyroidectomy and to validate the Bethesda System for Reporting Thyroid Cytopathology (TBSRTC).Methods: Data from 366 patients who underwent thyroidectomy between 2014-2016 were analyzed retrospectively and the variables related tothyroid cancer were investigated.Results: Of 366 patients, 44 (12%) were male and 322 (88%) were female. Regarding FNAB results according to TBSRTC, 23 (6.3%) patients had categoryI, 79 (21.6%) had category II, 128 (35%) had category III, 113 (30.9%) had category IV, nine (3.8%) patients had category V and 14 (2.5%) had category VIcytology. Histopathological examination revealed thyroid cancer in 65 (17.7%) patients. The Bethesda System was found to have a sensitivity of 73.9%and a specificity of 96%. There was no association between thyroid cancer and other variables except male gender.Conclusion: Although TBSRTC has an acceptable sensitivity and specificity, the risk of malignancy in category III and IV patients may vary. Therefore,multidisciplinary approach should be considered during treatment planning and surgical treatment option should be kept in mind.

🔖

Cite This Article

OCAK, S., BÜK, Ö. F., YEMEZ, K. (2022). Results of the Bethesda System in Patients Undergoing Thyroidectomy-A Single-Center Experience. European Archives of Medical Research, Cilt: 35 - Sayı: 2, 71–76. https://ajindex.com/articles/510437

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Guth S, Theune U, Aberle J, Galach A, Bamberger CM. Very high prevalence of thyroid nodules detected by high frequency (13 MHz) ultrasound examination. Eur J Clin Invest 2009;39:699-706
  2. Kim YY, Han K, Kim EK, Moon HJ, Yoon JH, Park VY, et al. Validation of the 2015 American thyroid association management guidelines for thyroid nodules with benign cytologic findings in the era of the Bethesda system. AJR Am J Roentgenol 2018:210:629-34
  3. Polyzos SA, Kita M, Avramidis A. Thyroid Stepwise diagnosis and management. Hormones 2007;6:101-19
  4. Cibas ES, Ali SZ. The Bethesda system for reporting thyroid cytopathology. Am J Clin Pathol 2009;132:658-65
  5. La Vecchia C, Malvezzi M, Bosetti C, Garavello W, Bertuccio P, Levi F, et al. Thyroid cancer mortality and incidence: a global overview. Int J Cancer 2015;136:2187-95
  6. Yassa L, Cibas ES, Benson CB, Frates MC, Doubilet PM, Gawande AA, et al. Long-term assessment of a multidisciplinary approach to thyroid nodule diagnostic evaluation. Cancer 2007;111:508-16
  7. Theoharis CG, Schofield KM, Hammers L, Udelsman R, Chhieng DC. The Bethesda thyroid fine-needle aspiration classification system: year 1 at an academic institution. Thyroid 2009;19:1215-23
  8. Luu MH, Fischer AH, Pisharodi L, Owens CL. Improved preoperative definitive diagnosis of papillary thyroid carcinoma in FNAs prepared with both ThinPrep and conventional smears compared with FNAs prepared with ThinPrep alone. Cancer Cytopathol 2009;119:68-73
  9. Bongiovanni M, Spitale A, Faquin WC, Mazzucchelli L, Baloch ZW. The Bethesda system for reporting thyroid cytopathology: a meta-analysis. Acta Cytol 2012;56:333-9
  10. Nayar R, Ivanovic M.The indeterminate thyroid fine-needle aspiration: experience from an academic center using terminology similar to that proposed in the 2007 National Cancer Institute Thyroid Fine Needle Aspiration State of the Science Conference. Cancer 2009;117:195-202
  11. Chehade JM, Silverberg AB, Kim J, Case C, Mooradian A. Role of repeated fine-needle aspiration of thyroid nodules with benign cytologic features. Endocr Pract 2001;7:237-43
  12. Orlandi A, Puscar A, Capriata E, Fideleff H. Repeated fine-needle aspiration of the thyroid in benign nodular thyroid disease: critical evaluation of longterm follow-up. Thyroid 2005;15:274-8
  13. Oertel YC, Miyahara-Felipe L, Mendoza MG, Yu K. Value of repeated fine needle aspirations of the thyroid: an analysis of over ten thousand FNAs. Thyroid 2007;17:1061-6
  14. Erdogan MF, Kamel N